Canada markets closed

Janux Therapeutics, Inc. (JANX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
12.46-1.34 (-9.71%)
At close: 04:00PM EDT
12.46 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 496.64M
Enterprise Value 135.59M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)101.90
Price/Book (mrq)1.39
Enterprise Value/Revenue 27.98
Enterprise Value/EBITDA -3.10

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-57.02%
S&P500 52-Week Change 3-6.69%
52 Week High 335.73
52 Week Low 39.39
50-Day Moving Average 312.69
200-Day Moving Average 315.76

Share Statistics

Avg Vol (3 month) 386.56k
Avg Vol (10 day) 341.36k
Shares Outstanding 541.63M
Implied Shares Outstanding 6N/A
Float 813.96M
% Held by Insiders 111.01%
% Held by Institutions 196.67%
Shares Short (Jul 14, 2022) 43.34M
Short Ratio (Jul 14, 2022) 424.22
Short % of Float (Jul 14, 2022) 421.96%
Short % of Shares Outstanding (Jul 14, 2022) 48.03%
Shares Short (prior month Jun 14, 2022) 43.04M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-911.82%

Management Effectiveness

Return on Assets (ttm)-12.54%
Return on Equity (ttm)-21.02%

Income Statement

Revenue (ttm)4.85M
Revenue Per Share (ttm)0.14
Quarterly Revenue Growth (yoy)318.20%
Gross Profit (ttm)-22.6M
EBITDA -44M
Net Income Avi to Common (ttm)-43.8M
Diluted EPS (ttm)-1.30
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)361.2M
Total Cash Per Share (mrq)8.73
Total Debt (mrq)153k
Total Debt/Equity (mrq)0.04
Current Ratio (mrq)29.14
Book Value Per Share (mrq)8.60

Cash Flow Statement

Operating Cash Flow (ttm)-34.06M
Levered Free Cash Flow (ttm)-16.34M